Die Übersetzung dieser Seite ist experimentell und in Entwicklung. Wir freuen uns über Ihr !
POLYMED Aktienübersicht
Poly Medicure Limited produziert und vertreibt medizinische Geräte in Indien und international.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 5/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
Poly Medicure Limited Wettbewerber
Preisentwicklung & Leistung
| Historical stock prices | |
|---|---|
| Current Share Price | ₹1,795.65 |
| 52 Week High | ₹1,850.00 |
| 52 Week Low | ₹963.00 |
| Beta | 0.34 |
| 1 Month Change | 15.02% |
| 3 Month Change | 11.89% |
| 1 Year Change | 84.13% |
| 3 Year Change | 73.70% |
| 5 Year Change | 814.51% |
| Change since IPO | 4,900.94% |
Aktuelle Nachrichten und Updates
Poly Medicure's (NSE:POLYMED) Promising Earnings May Rest On Soft Foundations
May 25
Why You Should Care About Poly Medicure's (NSE:POLYMED) Strong Returns On Capital
May 12Poly Medicure Limited's (NSE:POLYMED) Share Price Not Quite Adding Up
Mar 23Recent updates
Poly Medicure's (NSE:POLYMED) Promising Earnings May Rest On Soft Foundations
May 25Why You Should Care About Poly Medicure's (NSE:POLYMED) Strong Returns On Capital
May 12Poly Medicure Limited's (NSE:POLYMED) Share Price Not Quite Adding Up
Mar 23Here's Why We Think Poly Medicure (NSE:POLYMED) Might Deserve Your Attention Today
Feb 15Poly Medicure (NSE:POLYMED) Seems To Use Debt Quite Sensibly
Jan 16Is Now The Time To Put Poly Medicure (NSE:POLYMED) On Your Watchlist?
Nov 14Poly Medicure (NSE:POLYMED) Has More To Do To Multiply In Value Going Forward
Oct 24Shareholders Will Probably Hold Off On Increasing Poly Medicure Limited's (NSE:POLYMED) CEO Compensation For The Time Being
Sep 22Poly Medicure (NSE:POLYMED) Is Increasing Its Dividend To ₹3.00
Sep 08Here's Why Poly Medicure (NSE:POLYMED) Can Manage Its Debt Responsibly
Aug 12Here's Why We Think Poly Medicure (NSE:POLYMED) Is Well Worth Watching
Jul 13Poly Medicure (NSE:POLYMED) Is Reinvesting At Lower Rates Of Return
Jun 16Be Wary Of Poly Medicure (NSE:POLYMED) And Its Returns On Capital
Mar 02We Think Poly Medicure (NSE:POLYMED) Can Stay On Top Of Its Debt
Feb 14Capital Allocation Trends At Poly Medicure (NSE:POLYMED) Aren't Ideal
Oct 16We Think Poly Medicure (NSE:POLYMED) Can Stay On Top Of Its Debt
Sep 28Poly Medicure (NSE:POLYMED) Has Affirmed Its Dividend Of ₹2.50
Sep 08Here's Why Poly Medicure (NSE:POLYMED) Can Manage Its Debt Responsibly
Jun 25A Look At The Intrinsic Value Of Poly Medicure Limited (NSE:POLYMED)
Jun 07Poly Medicure (NSE:POLYMED) Will Want To Turn Around Its Return Trends
May 23With EPS Growth And More, Poly Medicure (NSE:POLYMED) Is Interesting
Feb 23There Are Reasons To Feel Uneasy About Poly Medicure's (NSE:POLYMED) Returns On Capital
Feb 04Poly Medicure (NSE:POLYMED) Seems To Use Debt Quite Sensibly
Jan 12With EPS Growth And More, Poly Medicure (NSE:POLYMED) Is Interesting
Oct 14Poly Medicure (NSE:POLYMED) Could Easily Take On More Debt
Jul 07Poly Medicure (NSE:POLYMED) Will Will Want To Turn Around Its Return Trends
Jun 18Poly Medicure's (NSE:POLYMED) Solid Profits Have Weak Fundamentals
May 31Earnings Update: Here's Why Analysts Just Lifted Their Poly Medicure Limited (NSE:POLYMED) Price Target To ₹1,195
May 26Shareholders of Poly Medicure (NSE:POLYMED) Must Be Delighted With Their 448% Total Return
Mar 01I Ran A Stock Scan For Earnings Growth And Poly Medicure (NSE:POLYMED) Passed With Ease
Feb 16How Much Is Poly Medicure Limited (NSE:POLYMED) CEO Getting Paid?
Feb 01Did Poly Medicure Limited (NSE:POLYMED) Insiders Sell Shares?
Jan 17Poly Medicure Limited's (NSE:POLYMED) Stock Is Going Strong: Is the Market Following Fundamentals?
Dec 09
Announcing: Poly Medicure (NSE:POLYMED) Stock Increased An Energizing 205% In The Last Five Years
Nov 24Is Poly Medicure (NSE:POLYMED) Using Too Much Debt?
Nov 09Many Would Be Jealous Of Poly Medicure's (NSE:POLYMED) Returns On Capital
Oct 26Have Insiders Been Selling Poly Medicure Limited (NSE:POLYMED) Shares?
Oct 06Should You Be Adding Poly Medicure (NSE:POLYMED) To Your Watchlist Today?
Sep 17Should Poly Medicure Limited (NSE:POLYMED) Be Part Of Your Dividend Portfolio?
Sep 02Is Poly Medicure Limited's (NSE:POLYMED) Latest Stock Performance A Reflection Of Its Financial Health?
Aug 19Aktionärsrenditen
| POLYMED | IN Medical Equipment | IN Markt | |
|---|---|---|---|
| 7D | 9.4% | 8.3% | 2.2% |
| 1Y | 84.1% | 74.4% | 45.0% |
Rendite im Vergleich zur Industrie: POLYMED übertraf die Branche Indian Medical Equipment , die im vergangenen Jahr eine Rendite von 60.7 erzielte.
Rendite vs. Markt: POLYMED übertraf den Markt Indian, der im vergangenen Jahr eine Rendite von 42.6 erzielte.
Preisvolatilität
| POLYMED volatility | |
|---|---|
| POLYMED Average Weekly Movement | 4.4% |
| Medical Equipment Industry Average Movement | 7.0% |
| Market Average Movement | 6.4% |
| 10% most volatile stocks in IN Market | 9.4% |
| 10% least volatile stocks in IN Market | 4.1% |
Stabiler Aktienkurs: POLYMED hatte in den letzten 3 Monaten keine nennenswerte Preisvolatilität.
Volatilität im Zeitverlauf: POLYMEDDie wöchentliche Volatilität (5%) ist im vergangenen Jahr stabil geblieben.
Über das Unternehmen
| Gegründet | Mitarbeiter | CEO | Website |
|---|---|---|---|
| 1995 | 2,339 | Himanshu Baid | www.polymedicure.com |
Poly Medicure Limited produziert und vertreibt medizinische Geräte in Indien und international. Das Unternehmen bietet Infusionsgeräte wie intravenöse Kanülen, Mid-Line-Katheter, arterielle Kanülen, Drei-Wege-Hähne, intravenöse Infusionssets, Verteiler, Infusionssets mit Sicherheitsflügeln, T-Typ-Verlängerungssets, Stylet/Mandrin mit Luer-Locks, Vial Access Spikes, Sets für die Verabreichung von Flüssigkeiten mit gemessenem Volumen, Verlängerungsleitungen, zentrale Venenkatheter, CVP-Manometer, nadelfreie Konnektoren, vorgefüllte Spritzen, vaskuläre Zugänge und Blutverabreichungssets. Das Unternehmen bietet auch nasogastrale und Säuglingsernährungssonden, gastro-duodenale Ernährungssonden und Nabelkatheter, Urinsammelbeutel, Foley-Ballon-Katheter, Spülsets, Urindrainagekatheter und Urinsammelbeutel mit Volumenmessgeräten sowie Endotracheal- und Tracheostomiekanülen, Schleimabsauger, Beatmungsschlauchsysteme, Bain-Schlauchsysteme, Katheterhalterungen, Wirbelsäulennadeln, HME-Filter und Larynxmasken.
Poly Medicure Limited's Grundlagenzusammenfassung
| POLYMED grundlegende Statistiken | |
|---|---|
| Marktanteil | ₹172.29b |
| Gewinn(TTM) | ₹2.58b |
| Umsatz(TTM) | ₹13.76b |
66.7x
Kurs-Gewinn-Verhältnis12.5x
Kurs-Umsatz-VerhältnisIst POLYMED zu teuer?
Siehe Fair Value und BewertungsanalyseErträge & Einnahmen
| POLYMED Gewinn- und Verlustrechnung (TTM) | |
|---|---|
| Einnahmen | ₹13.76b |
| Kosten der Einnahmen | ₹4.83b |
| Bruttogewinn | ₹8.93b |
| Sonstige Ausgaben | ₹6.35b |
| Umsatz | ₹2.58b |
Zuletzt gemeldete Gewinne
Mar 31, 2024
Datum des nächsten Gewinnberichts
k.A.
| Gewinn per Aktie (EPS) | 26.91 |
| Bruttomarge | 64.92% |
| Nettogewinnspanne | 18.77% |
| Schulden/Eigenkapital-Verhältnis | 11.6% |
Wie hat sich POLYMED auf lange Sicht entwickelt?
Historische Performance und Vergleiche